a developer of novel antibody therapeutics for oncology targets
Industry Biotechnology
A.I.dvisor indicates that over the last year, YMAB has been loosely correlated with RCKT. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if YMAB jumps, then RCKT could also see price increases.
Ticker / NAME | Correlation To YMAB | 1D Price Change % | ||
---|---|---|---|---|
YMAB | 100% | -2.95% | ||
RCKT - YMAB | 41% Loosely correlated | -0.91% | ||
IDYA - YMAB | 40% Loosely correlated | -1.24% | ||
PLRX - YMAB | 38% Loosely correlated | -0.47% | ||
SNDX - YMAB | 37% Loosely correlated | +1.14% | ||
PGEN - YMAB | 37% Loosely correlated | +5.17% | ||
More |